NCT03254914View on ClinicalTrials.gov

Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

CompletedOBSERVATIONAL
Enrollment

3,554

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

February 28, 2019

Conditions
Hypertension
Interventions
PROCEDURE

Home Blood Pressure

Measure Home Blood Pressure

Trial Locations (1)

Unknown

Seoul national university hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT03254914 - Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study | Biotech Hunter | Biotech Hunter